You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》藥明巨諾(02126.HK)反覆續升近6%創上市新高
阿思達克 11-06 14:42
上市第四天的藥明巨諾(02126.HK)繼首掛及上市翌日「潛水」兼曾跌破招股範圍(20-23.8元)下限低見19.38元獲承接後,股價上市第三天急彈逾19%,今天低開再考驗上市價23.8元不破,掉頭升破首掛日盤中所創高位25.45元,最高見27.6元上市新高,現造26.5元,續升5.8%,成交已達1,328萬股,涉資3.478億元。

藥明巨諾是內地臨床及臨床前階段細胞治療公司,由藥明康德(02359.HK)及美國醫藥研發平台Juno共同投資。是次來港上市共發售9,769.2萬股,並已引入10名機構投資者或基金作為基石投資者,合共認購逾4,884萬股;公開發售部分獲逾448倍超購,認購一手中籤率僅5%。上市聯席保薦人分別為高盛及瑞銀。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account